Setting

Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248424 | Pages: 194

Global pharmaceutical contract research organization (CRO) market will reach $45.0 billion by 2030, growing by 9.8% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 118 tables and 80 figures, this 194-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region. Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • CRO for Pre-clinical Development • CRO for Phase I Trials • CRO for Phase II Trials • CRO for Phase III Trials • CRO for Phase IV Trials • Laboratory Services • Consulting Services • Data Management Services Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Infectious Diseases • Oncology • Metabolic Disorders • Cardiovascular Disorders • Central Nervous System • Respiratory Disorders • Gastrointestinal Disorders • Other Therapeutic Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section. • Pharmaceutical & Biopharmaceutical Companies • Medical Device Companies • Academic Institutes Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories CMIC Co. Ltd Covance Inc. Hangzhou Tigermed Consulting Co., Ltd. ICON Plc IQVIA Holdings Inc. LSK Global Pharma Service Co., Ltd. Novotech Pty Ltd PAREXEL International Corporation Pharmaceutical Product Development LLC (PPD) PRA Health Sciences Inc. Quanticate Ltd Samsung Bioepis Co., Ltd. SGS SA (SGS Life Sciences) Syneos Health Inc. WuXi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 16 1.2.6 Market Size/Share Estimation 17 1.2.7 Research Limitations 18 1.3 Executive Summary 19 2 Market Overview and Dynamics 22 2.1 Market Size and Forecast 22 2.1.1 Impact of COVID-19 on World Economy 23 2.1.2 Impact of COVID-19 on the Market 25 2.2 Major Growth Drivers 27 2.3 Market Restraints and Challenges 35 2.4 Emerging Opportunities and Market Trends 38 2.5 Porter’s Fiver Forces Analysis 42 3 Segmentation of Global Market by Service 46 3.1 Market Overview by Service 46 3.2 CRO for Pre-clinical Development 48 3.3 CRO for Phase I Trials 49 3.4 CRO for Phase II Trials 50 3.5 CRO for Phase III Trials 51 3.6 CRO for Phase IV Trials 52 3.7 Laboratory Services 53 3.8 Consulting Services 54 3.9 Data Management Services 55 4 Segmentation of Global Market by Therapeutic Application 56 4.1 Market Overview by Therapeutic Application 56 4.2 Infectious Diseases 58 4.3 Oncology 59 4.4 Metabolic Disorders 60 4.5 Cardiovascular Disorders 61 4.6 Central Nervous System 62 4.7 Respiratory Disorders 63 4.8 Gastrointestinal Disorders 64 4.9 Other Therapeutic Applications 65 5 Segmentation of Global Market by End User 66 5.1 Market Overview by End User 66 5.2 Pharmaceutical & Biopharmaceutical Companies 68 5.3 Medical Device Companies 69 5.4 Academic Institutes 70 6 Segmentation of Global Market by Region 71 6.1 Geographic Market Overview 2019-2030 71 6.2 North America Market 2019-2030 by Country 75 6.2.1 Overview of North America Market 75 6.2.2 U.S. 79 6.2.3 Canada 82 6.2.4 Mexico 84 6.3 European Market 2019-2030 by Country 86 6.3.1 Overview of European Market 86 6.3.2 Germany 90 6.3.3 UK 92 6.3.4 France 94 6.3.5 Spain 96 6.3.6 Italy 98 6.3.7 Russia 100 6.3.8 Rest of European Market 102 6.4 Asia-Pacific Market 2019-2030 by Country 104 6.4.1 Overview of Asia-Pacific Market 104 6.4.2 Japan 108 6.4.3 China 111 6.4.4 Australia 113 6.4.5 India 115 6.4.6 South Korea 117 6.4.7 Rest of APAC Region 119 6.5 South America Market 2019-2030 by Country 121 6.5.1 Argentina 124 6.5.2 Brazil 126 6.5.3 Chile 128 6.5.4 Rest of South America Market 130 6.6 MEA Market 2019-2030 by Country 131 6.6.1 UAE 134 6.6.2 Saudi Arabia 136 6.6.3 South Africa 138 6.6.4 Other National Markets 140 7 Competitive Landscape 141 7.1 Overview of Key Vendors 141 7.2 New Product Launch, Partnership, Investment, and M&A 145 7.3 Company Profiles 146 Charles River Laboratories 146 CMIC Co. Ltd 148 Covance Inc. 150 Hangzhou Tigermed Consulting Co., Ltd. 154 ICON Plc 157 IQVIA Holdings Inc. 160 LSK Global Pharma Service Co., Ltd. 164 Novotech Pty Ltd 166 PAREXEL International Corporation 168 Pharmaceutical Product Development LLC (PPD) 172 PRA Health Sciences Inc. 174 Quanticate Ltd 176 Samsung Bioepis Co., Ltd. 178 SGS SA (SGS Life Sciences) 180 Syneos Health Inc. 183 WuXi AppTec Inc. 186 8 Investing in Global Market: Risk Assessment and Management 188 8.1 Risk Evaluation of Global Market 188 8.2 Critical Success Factors (CSFs) 191 Related Reports and Products 194
List Of Tables:
Table 1. Snapshot of Global Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 20 Table 2. World Economic Outlook, 2021-2030 24 Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 29 Table 4. Worldwide Total Number of Registered Clinical Trials 31 Table 5. World Health Spending by Region, $ bn, 2013-2020 34 Table 6. Main Product Trends and Market Opportunities in Global Pharmaceutical CRO Market 38 Table 7. Global Pharmaceutical CRO Market by Service, 2019-2030, $ bn 46 Table 8. Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 56 Table 9. Global Pharmaceutical CRO Market by End User, 2019-2030, $ bn 66 Table 10. Global Pharmaceutical CRO Market by Region, 2019-2030, $ bn 72 Table 11. Leading National Pharmaceutical CRO Market, 2021 and 2030, $ bn 74 Table 12. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 77 Table 13. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn 81 Table 14. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 81 Table 15. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn 81 Table 16. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn 83 Table 17. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 83 Table 18. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn 83 Table 19. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn 85 Table 20. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 85 Table 21. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn 85 Table 22. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 89 Table 23. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 91 Table 24. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 91 Table 25. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 91 Table 26. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 93 Table 27. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 93 Table 28. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 93 Table 29. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 95 Table 30. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 95 Table 31. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 95 Table 32. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 97 Table 33. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 97 Table 34. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 97 Table 35. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 99 Table 36. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 99 Table 37. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 99 Table 38. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 101 Table 39. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 101 Table 40. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 101 Table 41. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 103 Table 42. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 106 Table 43. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 110 Table 44. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 110 Table 45. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 110 Table 46. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 112 Table 47. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 112 Table 48. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 112 Table 49. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 114 Table 50. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 114 Table 51. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 114 Table 52. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 116 Table 53. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 116 Table 54. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 116 Table 55. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 118 Table 56. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 118 Table 57. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 118 Table 58. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 120 Table 59. South America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 123 Table 60. Argentina Pharmaceutical CRO Market by Service, 2019-2030, $ bn 125 Table 61. Argentina Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 125 Table 62. Argentina Pharmaceutical CRO Market by End User, 2019-2030, $ bn 125 Table 63. Brazil Pharmaceutical CRO Market by Service, 2019-2030, $ bn 127 Table 64. Brazil Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 127 Table 65. Brazil Pharmaceutical CRO Market by End User, 2019-2030, $ bn 127 Table 66. Chile Pharmaceutical CRO Market by Service, 2019-2030, $ bn 129 Table 67. Chile Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 129 Table 68. Chile Pharmaceutical CRO Market by End User, 2019-2030, $ bn 129 Table 69. MEA Pharmaceutical CRO Market by Country, 2019-2030, $ bn 133 Table 70. UAE Pharmaceutical CRO Market by Service, 2019-2030, $ bn 135 Table 71. UAE Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 135 Table 72. UAE Pharmaceutical CRO Market by End User, 2019-2030, $ bn 135 Table 73. Saudi Arabia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 137 Table 74. Saudi Arabia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 137 Table 75. Saudi Arabia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 137 Table 76. South Africa Pharmaceutical CRO Market by Service, 2019-2030, $ bn 139 Table 77. South Africa Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 139 Table 78. South Africa Pharmaceutical CRO Market by End User, 2019-2030, $ bn 139 Table 79. Breakdown of World Market by Key Vendor, 2020, % 143 Table 80. Charles River Laboratories: Company Snapshot 146 Table 81. Charles River Laboratories: Product Portfolio 147 Table 82. CMIC Co. Ltd.: Company Snapshot 148 Table 83. CMIC Co. Ltd.: Business Segmentation 149 Table 84. CMIC Co. Ltd.: Revenue by Region, 2018, % 149 Table 85. Covance Inc.: Company Snapshot 150 Table 86. Covance Inc.: Product Portfolio 151 Table 87. Covance Inc.: Revenue by Region, 2020, % 152 Table 88. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot 154 Table 89. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation 155 Table 90. ICON Plc: Company Snapshot 157 Table 91. ICON Plc: Business Segmentation 157 Table 92. ICON Plc: Product Portfolio 158 Table 93. ICON Plc: Revenue by Region, 2020, % 158 Table 94. IQVIA Holdings Inc.: Company Snapshot 160 Table 95. IQVIA Holdings Inc.: Business Segmentation 161 Table 96. IQVIA Holdings Inc.: Revenue by Region, 2020, % 161 Table 97. IQVIA Holdings Inc.: Product Portfolio 162 Table 98. LSK Global Pharma Service Co., Ltd.: Company Snapshot 164 Table 99. Novotech Pty Ltd: Company Snapshot 166 Table 100. PAREXEL International Corporation: Company Snapshot 168 Table 101. PAREXEL International Corporation: Business Segmentation 169 Table 102. PAREXEL International Corporation: Revenue by Region, 2018, % 169 Table 103. PAREXEL International Corporation: Product Portfolio 170 Table 104. Pharmaceutical Product Development LLC (PPD): Company Snapshot 172 Table 105. PRA Health Sciences Inc.: Company Snapshot 174 Table 106. PRA Health Sciences Inc.: Business Segmentation 175 Table 107. PRA Health Sciences Inc.: Revenue by Region, 2018, % 175 Table 108. Quanticate Ltd: Company Snapshot 176 Table 109. Samsung Bioepis Co., Ltd.: Company Snapshot 178 Table 110. SGS SA (SGS Life Sciences): Company Snapshot 180 Table 111. SGS SA (SGS Life Sciences): Business Segmentation 181 Table 112. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 181 Table 113. Syneos Health Inc.: Company Snapshot 183 Table 114. Syneos Health Inc.: Business Segmentation 184 Table 115. Syneos Health Inc.: Revenue by Region, 2018, % 184 Table 116. WuXi AppTec Inc.: Company Snapshot 186 Table 117. Risk Evaluation for Investing in Global Market, 2021-2030 189 Table 118. Critical Success Factors and Key Takeaways 192
List Of Figures:
Figure 1. Research Method Flow Chart 13 Figure 2. Breakdown of Primary Research 15 Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 17 Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 19 Figure 5. Global Pharmaceutical CRO Market, 2019-2030, $ bn 22 Figure 6. Impact of COVID-19 on Business 25 Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical CRO Market 27 Figure 8. Leading Causes of Death in the World, 2019-2020, million 32 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33 Figure 11. Primary Restraints and Impact Factors of Global Pharmaceutical CRO Market 35 Figure 12. Investment Opportunity Analysis 39 Figure 13. Porter’s Fiver Forces Analysis of Global Pharmaceutical CRO Market 42 Figure 14. Breakdown of Global Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 47 Figure 15. Global Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 47 Figure 16. Global Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 48 Figure 17. Global Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 49 Figure 18. Global Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 50 Figure 19. Global Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 51 Figure 20. Global Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 52 Figure 21. Global Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 53 Figure 22. Global Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 54 Figure 23. Global Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 55 Figure 24. Breakdown of Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 57 Figure 25. Global Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 57 Figure 26. Global Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 58 Figure 27. Global Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 59 Figure 28. Global Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 60 Figure 29. Global Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 61 Figure 30. Global Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 62 Figure 31. Global Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 63 Figure 32. Global Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 64 Figure 33. Global Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 65 Figure 34. Breakdown of Global Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 67 Figure 35. Global Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 67 Figure 36. Global Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 68 Figure 37. Global Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 69 Figure 38. Global Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 70 Figure 39. Global Market Snapshot by Region 71 Figure 40. Geographic Spread of Worldwide Pharmaceutical CRO Market, 2019-2030, % of Sales Revenue 72 Figure 41. Global Addressable Market Cap in 2022-2030 by Region, Value ($ bn) and Share (%) 73 Figure 42. North American Pharmaceutical CRO Market, 2019-2030, $ bn 76 Figure 43. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 77 Figure 44. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 78 Figure 45. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn 80 Figure 46. Canada Pharmaceutical CRO Market, 2019-2030, $ bn 82 Figure 47. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn 84 Figure 48. European Pharmaceutical CRO Market, 2019-2030, $ bn 87 Figure 49. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 88 Figure 50. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 89 Figure 51. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 90 Figure 52. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 92 Figure 53. Pharmaceutical CRO Market in France, 2019-2030, $ bn 94 Figure 54. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 96 Figure 55. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 98 Figure 56. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 100 Figure 57. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 102 Figure 58. Asia-Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 105 Figure 59. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 105 Figure 60. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 107 Figure 61. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 109 Figure 62. Pharmaceutical CRO Market in China, 2019-2030, $ bn 111 Figure 63. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 113 Figure 64. Pharmaceutical CRO Market in India, 2019-2030, $ bn 115 Figure 65. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 117 Figure 66. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 119 Figure 67. South America Pharmaceutical CRO Market, 2019-2030, $ bn 122 Figure 68. Breakdown of South America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 122 Figure 69. Contribution to South America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 123 Figure 70. Pharmaceutical CRO Market in Argentina, 2019-2030, $ bn 124 Figure 71. Pharmaceutical CRO Market in Brazil, 2019-2030, $ bn 126 Figure 72. Pharmaceutical CRO Market in Chile, 2019-2030, $ bn 128 Figure 73. Pharmaceutical CRO Market in Rest of South America, 2019-2030, $ bn 130 Figure 74. Pharmaceutical CRO Market in MEA, 2019-2030, $ bn 132 Figure 75. Breakdown of MEA Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 132 Figure 76. Contribution to MEA 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 133 Figure 77. Pharmaceutical CRO Market in UAE, 2019-2030, $ bn 134 Figure 78. Pharmaceutical CRO Market in Saudi Arabia, 2019-2030, $ bn 136 Figure 79. Pharmaceutical CRO Market in South Africa, 2019-2030, $ bn 138 Figure 80. Growth Stage of Global Pharmaceutical CRO Industry over the Forecast Period 141
Selected Key Players: 
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)